Method for determination of 24-28 weeks treatment efficacy in patients with chronic hepatitis C on remission stage

Valentīna Sondore; Agita Jēruma; Natalija Sevastjanova; Ludmila Vīksna

Method for determination of 24-28 weeks treatment efficacy in patients with chronic hepatitis C on remission stage

Translated title of the contribution: Ārstēšanas efektivitātes noteikšanas paņēmiens hroniska vīrushepatīta C slimniekiem remisijas stadijā pēc 24-48 nedēļu ārstēšanas

Valentīna Sondore (Inventor)
, Agita Jēruma (Inventor)
, Natalija Sevastjanova (Inventor)
, Ludmila Vīksna (Inventor)

Rīga Stradiņš University

Research output: Innovations, Intellectual property, Prototypes › Patent

Abstract

Invention relates to medicine and particularly to methods for evalutation of efficacy of treatment of hepatitis C. The method provides for determination of serum level of cytokeratin‑18 neoepitope. If the serum level is 129 U/L or lower the efficacy of the treatment is established.

Translated title of the contribution	Ārstēšanas efektivitātes noteikšanas paņēmiens hroniska vīrushepatīta C slimniekiem remisijas stadijā pēc 24-48 nedēļu ārstēšanas
Original language	Latvian
Patent number	14923
IPC	G01N33/53
Priority date	28/05/14
Filing date	28/05/14
Publication status	Published - 20 Jan 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords*

methods for evalutation of efficacy of treatment of hepatitis C

Field of Science

3.2 Clinical medicine

Access to Document

http://databases.lrpv.gov.lv/databases/lv/patent/details/p-14-43/

Cite this

@misc{4d7830d131144b74ad57ef1a10783cba,

title = "Method for determination of 24-28 weeks treatment efficacy in patients with chronic hepatitis C on remission stage",

abstract = "Invention relates to medicine and particularly to methods for evalutation of efficacy of treatment of hepatitis C. The method provides for determination of serum level of cytokeratin‑18 neoepitope. If the serum level is 129 U/L or lower the efficacy of the treatment is established.",

keywords = "methods for evalutation of efficacy of treatment of hepatitis C",

author = "Valentīna Sondore and Agita Jēruma and Natalija Sevastjanova and Ludmila Vīksna",

year = "2015",

month = jan,

day = "20",

language = "Latvian",

publisher = "Patent Office of the Republic of Latvia",

type = "Patent",

note = "14923; G01N33/53",

}

TY - PAT

T1 - Method for determination of 24-28 weeks treatment efficacy in patients with chronic hepatitis C on remission stage

AU - Sondore, Valentīna

AU - Jēruma, Agita

AU - Sevastjanova, Natalija

AU - Vīksna, Ludmila

PY - 2015/1/20

Y1 - 2015/1/20

N2 - Invention relates to medicine and particularly to methods for evalutation of efficacy of treatment of hepatitis C. The method provides for determination of serum level of cytokeratin‑18 neoepitope. If the serum level is 129 U/L or lower the efficacy of the treatment is established.

AB - Invention relates to medicine and particularly to methods for evalutation of efficacy of treatment of hepatitis C. The method provides for determination of serum level of cytokeratin‑18 neoepitope. If the serum level is 129 U/L or lower the efficacy of the treatment is established.

KW - methods for evalutation of efficacy of treatment of hepatitis C

UR - https://www.lrpv.gov.lv/lv/media/1060/download

M3 - Patent

M1 - 14923

Y2 - 2014/05/28

PB - Patent Office of the Republic of Latvia

ER -

Method for determination of 24-28 weeks treatment efficacy in patients with chronic hepatitis C on remission stage

Abstract

UN SDGs

Keywords*

Field of Science

Access to Document

Other files and links

Fingerprint

Cite this